Cargando…

CA19-9 as a prognostic factor in inoperable pancreatic cancer: the implication for clinical trials

In a multivariate analysis of 154 patients receiving chemotherapy, baseline CA19-9 was an independent prognostic factor for overall survival (OS) (HR 1.8; 95% CI: 1.3–2.5, P=0.0004). The 1-year OS was 19 and 46%, respectively, for patients with a baseline CA19-9 above or below the median value. A fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maisey, N R, Norman, A R, Hill, A, Massey, A, Oates, J, Cunningham, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361637/ https://www.ncbi.nlm.nih.gov/pubmed/16175188 http://dx.doi.org/10.1038/sj.bjc.6602760

Ejemplares similares

Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine
por: Ziske, C, et al.
Publicado: (2003)

Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer
por: Crumley, A B C, et al.
Publicado: (2006)

The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract
por: Formica, V, et al.
Publicado: (2007)

A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer
por: Evans, T R J, et al.
Publicado: (2002)

Analysis of the time course and prognostic factors determining toxicity due to infused fluorouracil
por: Tebbutt, N C, et al.
Publicado: (2003)

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer
por: Rao, S, et al.
Publicado: (2005)

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan
por: Chong, G, et al.
Publicado: (2005)

Oxaliplatin combined with infusional 5-fluorouracil and concomitant radiotherapy in inoperable and metastatic rectal cancer: a phase I trial
por: Loi, S, et al.
Publicado: (2005)

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
por: Sumpter, K, et al.
Publicado: (2005)

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II study
por: Valle, J W, et al.
Publicado: (2005)

Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool
por: Chira, Ciprian, et al.
Publicado: (2013)

The Role of Redox-Regulating Enzymes in Inoperable Breast Cancers Treated with Neoadjuvant Chemotherapy
por: Roininen, Nelli, et al.
Publicado: (2017)

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer
por: Ko, A H, et al.
Publicado: (2005)

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer
por: Rao, S, et al.
Publicado: (2008)

Serum CA19-9 Level Associated with Metabolic Control and Pancreatic Beta Cell Function in Diabetic Patients
por: Yu, Haoyong, et al.
Publicado: (2012)

Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer
por: Zhu, Xiaofei, et al.
Publicado: (2017)

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy
por: Bernhard, J, et al.
Publicado: (2010)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Modelling prognostic factors in advanced pancreatic cancer
por: Stocken, D D, et al.
Publicado: (2008)

Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers – a new active regimen
por: Slater, S, et al.
Publicado: (2002)

The Ultimate Results of Inoperable Gynæcological Cases
por: Giles, A. E.
Publicado: (1907)

Treatment of an Inoperable Pancreatic Cyst
por: Gupta, S. C. Das
Publicado: (1936)

Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials
por: Smith, N J, et al.
Publicado: (2007)

Colorectal Carcinoma with Extremely Low CA19-9
por: Kawamura, Yutaka J., et al.
Publicado: (2009)

Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer
por: Rudra, Soumon, et al.
Publicado: (2019)

Inoperable Cancer
Publicado: (1901)

Gastrazole (JB95008), a novel CCK2/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials
por: Chau, I, et al.
Publicado: (2006)

Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarcinoma of the pancreas?
por: Gogas, H., et al.
Publicado: (1998)

Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?
por: Chau, I, et al.
Publicado: (2003)

The prognostic and predictive value of serum CA19.9 in pancreatic cancer
por: Humphris, J. L., et al.
Publicado: (2012)

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma
por: Starling, N, et al.
Publicado: (2009)

Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer
por: Antonio, Maite, et al.
Publicado: (2018)

Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer
por: Rao, S, et al.
Publicado: (2004)

Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma
por: Ng, M, et al.
Publicado: (2005)

Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

Pancreatic Resections in Renal Failure Patients: Is It Worth the Risk?
por: Norman, K. S., et al.
Publicado: (2014)

Optimization of biliary drainage in inoperable distal malignant strictures
por: Elshimi, Esam, et al.
Publicado: (2020)

The Hyperdense Internal Carotid Artery Sign: Prevalence and Prognostic Relevance in Stroke Thrombolysis
por: Fitzsimmons, P. R., et al.
Publicado: (2011)

Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer
por: Saini, A, et al.
Publicado: (2003)

Elderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy
por: Chau, I, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_2qak7r7uaodv8i5j3q4q1bsbsq